Anpario plc
("Anpario" or the "Company")
Director/PDMR Shareholding
Anpario (AIM: ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, announces that it was notified on 21 March 2024, that on the same day, Marc Wilson, Group Finance Director of the Company, purchased 6,511 ordinary shares of 23p each in the Company ("Ordinary Shares") at a price of 233.25p each.
Following these purchases, the ultimate beneficial ownership of Marc Wilson in Anpario is 21,462 Ordinary Shares, representing 0.11% of the issued share capital of the Company.
Enquiries
Anpario plc | |
Richard Edwards, CEO | +44(0)7776 417 129 |
Marc Wilson, Group Finance Director | +44(0)1909 537 380 |
| |
Shore Capital | |
(Nominated Adviser and Broker): | +44 (0) 20 7408 4090 |
Stephane Auton | Corporate Advisory |
David Coaten | |
Tom Knibbs | |
Henry Willcocks | Corporate Broking |
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and their Closely Associated Persons
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name
| Marc Wilson | ||||
2 | Reason for the notification | |||||
|
| Group Finance Director | ||||
b) | Initial notification/Amendment
| Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Anpario plc | ||||
b) | LEI | 213800BZHUIUCH3MCC06 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 23 pence each in the Company ("Ordinary Shares")
ISIN GB00B3NWT178 | ||||
b) | Nature of the transaction
| Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s)
|
| ||||
d) | Aggregated information
|
| ||||
e) | Date of the transaction
| 21 March 2024 | ||||
f) | Place of the transaction
| London Stock Exchange (XLON), AIM |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.